Rate My Professor Antony Watson

Antony Watson serves as Research Assistant in the Department of Paediatrics and Child Health, Christchurch, University of Otago, within the Faculty of Medicine, Health Sciences Division. His contact details include the direct dial +64 3 364 3694 and email antony.watson@otago.ac.nz. Watson is affiliated with clinical research efforts documented in peer-reviewed publications spanning diabetes management and cardiovascular diagnostics.

Key publications co-authored by Antony Watson include: "Extended use of real-time continuous glucose monitoring in adults with type 2 diabetes using insulin: interim results from the 2GO-CGM trial" (Lever et al., Diabetic Medicine, 2025); "Acceptability and experiences of real-time continuous glucose monitoring in adults with type 2 diabetes using insulin: a qualitative study" (Sergel-Stringer et al., Journal of Diabetes and Metabolic Disorders, 2024); "Real time continuous glucose monitoring in high-risk people with type 2 diabetes: a service evaluation" (Lever et al., Diabetic Medicine, 2024); "Use of a decision support tool and quick start onboarding tool in individuals with type 1 diabetes using advanced automated insulin delivery: a single-arm multi-phase intervention study" (Sehgal et al., BMC Endocrine Disorders, 2024); "Study protocol: glycaemic outcomes in people with type 2 diabetes initiating insulin treated with real-time continuous glucose monitoring" (Lever et al., Journal of Diabetes and Metabolic Disorders, 2023); "A prospective multi-centre study assessing the safety and effectiveness following the implementation of an accelerated chest pain pathway using point-of-care troponin for use in New Zealand rural hospitals" (Miller et al., European Heart Journal: Acute Cardiovascular Care, 2022); "Study protocol for an observational study to evaluate an accelerated chest pain pathway using a point-of-care troponin device in New Zealand rural hospitals" (Miller et al., Journal of Primary Health Care, 2020); "Undetectable high-sensitivity troponin in combination with clinical assessment for risk stratification of patients with chest pain and normal troponin at hospital arrival" (Aldous et al., Emergency Medicine Australasia, 2020); "Early kinetic profiles of troponin I and T measured by high-sensitivity assays" (Watson et al., Clinica Chimica Acta, year not specified in sources); "Rapid Rule-out of Acute Myocardial Infarction With a Single High-Sensitivity Cardiac Troponin T Level" (Chew et al., Annals of Internal Medicine, 2017). These represent confirmed outputs from OUR Archive and associated journals.